Small molecules as pro-apoptotic anticancer agents.

Area of Science:

• Oncology
• Molecular Biology
• Medicinal Chemistry

Background:

• Apoptosis-related mechanisms are crucial for identifying novel anticancer therapies.
• Targeted therapies aim for potent and selective action against cancer cells.
• Small molecules represent a significant class of therapeutic agents in cancer research.

Purpose of the Study:

• To review small molecule-based anticancer drug candidates targeting apoptosis.
• To focus on five key target families influencing caspase-dependent apoptosis.
• To discuss current clinical trials and future trends in apoptosis-targeted cancer therapy.

Main Methods:

• Chemical review of small molecules targeting apoptosis.
• Analysis of five target families: caspase-3, Bcl-2, IAP proteins, p53, and the proteasome.
• Examination of drug candidates in clinical trials and patent literature since 2006.

Main Results:

• Identified drug candidates targeting caspase-3, Bcl-2, IAP proteins, p53, and the proteasome.
• Summarized relevant chemotypes from patent literature.
• Highlighted the involvement of these targets in tumor initiation and progression.

Conclusions:

• Small molecules targeting apoptosis represent a promising avenue for novel cancer therapies.
• Continued research into these targets and emerging chemotypes is essential.
• Future trends indicate significant advancements in apoptosis-targeted cancer treatments.